The Effects of Naturalistic Light on Post Stroke Complications Related Brain Areas in Stroke Patients During Admission for Rehabilitation.
Launched by RIGSHOSPITALET, DENMARK · Apr 3, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how natural sunlight, or "naturalistic light," can help improve issues like depression and fatigue in stroke patients during their rehabilitation. After a stroke, many patients experience significant fatigue (up to 85%) and depression (about 30%), which can greatly impact their recovery and overall quality of life. The researchers believe that exposure to naturalistic light might positively influence brain areas related to these problems, and they will use MRI scans and other tests to look for changes in brain function and health.
To participate, patients should be between 65 and 74 years old and have moderate to severe fatigue or depression. They must also be able to stay in a rehabilitation unit for at least 10 days. Unfortunately, those with severe communication difficulties, certain eye problems, or who are not able to cooperate with the study will not be eligible. If someone joins the trial, they can expect to undergo various assessments, including tests for fatigue and mood, MRI scans, and evaluations of their sleep and cognitive abilities, all while receiving care in an environment with natural lighting.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients scoring moderate-severe fatigue and/or depression OR NO fatigue and/or depressione which are evaluated as candidates for the rehabilitation unit.
- Exclusion Criteria:
- • GCS \< 15
- • No functioning nervus opticus or retina in both eyes
- • Unable to open both eyes
- • Non communicating patients e.g. severe aphasia (incompetent patients)
- • Unable to cooperate to the physical examinations
- • Less than 10 days of hospitalization in the rehabilitation department
- • Claustrophobia
- • If the sub investigator finds the study participant unfit to conduct the investigations
About Rigshospitalet, Denmark
Rigshospitalet, located in Copenhagen, Denmark, is one of the leading hospitals in Scandinavia and a prominent center for clinical research and innovation. As a key academic institution affiliated with the University of Copenhagen, Rigshospitalet is dedicated to advancing healthcare through rigorous clinical trials and groundbreaking research across various medical disciplines. The hospital’s commitment to excellence is reflected in its multidisciplinary approach, collaboration with international research networks, and focus on improving patient outcomes through evidence-based practices. With state-of-the-art facilities and a team of highly qualified professionals, Rigshospitalet plays a crucial role in translating scientific discoveries into effective treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Glostrup, Capital Region, Denmark
Patients applied
Trial Officials
Anders Sode West, MD, PhD
Principal Investigator
Rigshospitalet Glostrup
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported